Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. Summary
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
Delayed Australian Stock Exchange  -  02:11 2022-08-12 am EDT
0.1850 AUD   -5.13%
08/06RESAPP HEALTH : Pfizer raises scheme consideration to A$0.208 per share
PU
07/22RESAPP HEALTH : Study shows efficacy of ResAppDx use with masks
PU
07/21ResApp Health Validates Effectivity of Respiratory Diagnostic App in Mask-Wearing Patients; Shares Fall 4%
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
0.195(c) 0.19(c) 0.195(c) 0.195(c) 0.185(c) Last
10 378 248 2 874 699 3 103 696 2 320 298 11 920 498 Volume
+2.63% -2.56% +2.63% 0.00% -5.13% Change
More quotes
Estimated financial data (e)
Sales 2020 - - -
Net income 2020 -8,47 M - -
Net cash position 2020 5,45 M - -
P/E ratio 2020 -14,6x
Yield 2020 -
Sales 2021 0,07  - -
Net income 2021 -6,77 M - -
Net cash position 2021 6,40 M - -
P/E ratio 2021 -4,71x
Yield 2021 -
Capitalization 159 M 113 M -
EV / Sales 2020 -
EV / Sales 2021 413 455 192x
Nbr of Employees 510
Free-Float 81,0%
More Financials
Company
ResApp Health Limited is an Australia-based digital health company engaged in developing smartphone applications for the diagnosis and management of respiratory disease. The Company provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The Company is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and... 
Read more
Sector
Software
Calendar
08/31Earnings Release
More about the company
All news about RESAPP HEALTH LIMITED
08/06RESAPP HEALTH : Pfizer raises scheme consideration to A$0.208 per share
PU
07/22RESAPP HEALTH : Study shows efficacy of ResAppDx use with masks
PU
07/21ResApp Health Validates Effectivity of Respiratory Diagnostic App in Mask-Wearing Patie..
MT
07/20RESAPP HEALTH : Clarification - Scheme Booklet registered with ASIC
PU
07/17RESAPP HEALTH : Scheme Booklet registered with ASIC
PU
07/15ResApp Health Secures Court Orders for Scheme Deal
MT
07/08ResApp Health Agrees to One-Year Extension of Commercial License Deal
MT
07/06ResApp Health Limited Agrees to 12 Month Extension to its Commercial Licence Agreement ..
CI
07/06ResApp Health Secures US FDA Medical Device Clearance for Sleep Apnea Software
MT
07/05RESAPP HEALTH : Cough detection patent granted in Australia and Japan
PU
07/05RESAPP HEALTH : receives FDA 510(k) clearance for SleepCheckRx
PU
07/05ResApp Health Limited Receives FDA 510(K) Clearance for Sleepcheckrx
CI
07/04ResApp Health Gets Australian, Japanese Patents for Cough Detection Technology
MT
06/20ResApp Health Limited Announces Results from Data Confirmation Study
CI
06/16RESAPP HEALTH : Application for quotation of securities - RAP
PU
More news
News in other languages on RESAPP HEALTH LIMITED
07/21ResApp Health valide l'efficacité de l'application de diagnostic respiratoire chez les ..
07/15ResApp Health obtient des ordonnances judiciaires pour l'accord sur les régimes de retr..
07/06ResApp Health Limited accepte de prolonger de 12 mois son accord de licence commerciale..
07/06ResApp Health obtient l'autorisation de la FDA pour son logiciel sur l'apnée du sommeil..
07/05ResApp Health Limited reçoit l'autorisation 510(K) de la FDA pour Sleepcheckrx
More news
Chart RESAPP HEALTH LIMITED
Duration : Period :
ResApp Health Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESAPP HEALTH LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Tony Keating Chief Executive Officer, Executive Director & MD
Al Rey Lunar Vice President-Finance
Roger Aston Non-Executive Chairman
Christopher Ntoumenopoulos Non-Executive Director
Brian Leedman Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RESAPP HEALTH LIMITED184.62%113
SNAP INC.-75.29%19 161
KAKAO GAMES CORP.-35.49%3 514
ANGI INC.-42.67%2 657
DENA CO., LTD.7.74%1 613
FINVOLUTION GROUP-4.26%1 346